Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

被引：0
|
作者：
Martina Mayr
Karen Becker
Nadine Schulte
Sebastian Belle
Ralf Hofheinz
Annekatrin Krause
Roland M Schmid
Christoph Röcken
Matthias P Ebert
机构：
[1] Klinikum Rechts der Isar,Department of Internal Medicine II
[2] Technical University of Munich,Institute for Pathology, Klinikum Rechts der Isar
[3] Technical University of Munich,Department of Medicine II
[4] University Hospital Mannheim,Department of Medicine III
[5] Ruprecht-Karls-Universität Heidelberg,Institute of Pathology
[6] University Hospital Mannheim,undefined
[7] Ruprecht-Karls-Universität Heidelberg,undefined
[8] Novartis Pharma GmbH,undefined
[9] Christian-Albrechts Universität,undefined
来源：
BMC Cancer | / 12卷
关键词：
Imatinib; PDGF; Gastric cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma
    Mayr, Martina
    Becker, Karen
    Schulte, Nadine
    Belle, Sebastian
    Hofheinz, Ralf
    Krause, Annekatrin
    Schmid, Roland M.
    Roecken, Christoph
    Ebert, Matthias P.
    BMC CANCER, 2012, 12
  • [2] Phase I study of imatinib, cisplatin, and fluoruracil in patients with advanced gastric cancer.
    Mayr, Martina
    Alberter, Barbara
    Becker, Karin
    Schmid, Roland M.
    Ebert, Matthias Philip
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Neoadjuvant treatment with gemcitabine, cisplatin, 5-fluoruracil and accelerated hyperfractionated radiation therapy in advanced gastrointestinal malignancies: Results of a phase I study
    Landry, JC
    Harris, W
    Yang, GY
    Staley, C
    Bhalla, K
    RADIOLOGY, 2000, 217 : 147 - +
  • [4] Acute ischaemic cerebrovascular attack secondary to infusional 5-fluoruracil and cisplatin in a patient with advanced gastric cancer
    Ignacio Garrido-Laguna
    María de la Luz Amador
    Juan Ruiz
    Hernán Cortés-Funes
    Clinical and Translational Oncology, 2009, 11 : 183 - 185
  • [5] Acute ischaemic cerebrovascular attack secondary to infusional 5-fluoruracil and cisplatin in a patient with advanced gastric cancer
    Garrido-Laguna, Ignacio
    Amador, Maria de la Luz
    Ruiz, Juan
    Cortes-Funes, Hernan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (03): : 183 - 185
  • [6] Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
    Lee, K. -W.
    Park, S. R.
    Oh, D. -Y.
    Park, Y. -I.
    Khosravan, R.
    Lin, X.
    Lee, S. -Y.
    Roh, E. -J.
    Valota, O.
    Lechuga, M. J.
    Bang, Y. -J.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1547 - 1558
  • [7] Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
    K.-W. Lee
    S. R. Park
    D.-Y. Oh
    Y.-I. Park
    R. Khosravan
    X. Lin
    S.-Y. Lee
    E.-J. Roh
    O. Valota
    M. J. Lechuga
    Y.-J. Bang
    Investigational New Drugs, 2013, 31 : 1547 - 1558
  • [8] Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience
    Paolo Piacentini
    Emilia Durante
    Annarita Trolese
    Anna Mercanti
    Andrea Bonetti
    Gastric Cancer, 2012, 15 : 106 - 110
  • [9] Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience
    Piacentini, Paolo
    Durante, Emilia
    Trolese, Annarita
    Mercanti, Anna
    Bonetti, Andrea
    GASTRIC CANCER, 2012, 15 (01) : 106 - 110
  • [10] SURVIVAL OF PATIENTS WITH FAR-ADVANCED GASTRIC CANCER TREATED WITH 5-FLUORURACIL
    KORMAN, DB
    VOPROSY ONKOLOGII, 1978, 24 (07) : 51 - 55
12345